Fulcrum Therapeutics
$11.879876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-0.42%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell FULC and other stocks, options, and ETFs commission-free!
About FULC
Fulcrum Therapeutics, Inc. Common Stock, also called Fulcrum Therapeutics, is a clinical stage biopharmaceutical company.
CEO
Bryan E Stuart
Employees
73
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
374.15M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
97.36K
High Today
$12.08
Low Today
$11.59
Open Price
$11.86
Volume
55.83K
52 Week High
$22.39
52 Week Low
$7.01
Analyst Ratings
71%
of 7 ratings
Buy
71%
Hold
14%
Sell
14%
FULC Earnings
-$2.98
-$1.99
-$0.99
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market